V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190007201 | 190006777 | 1.6 | 95 | Curative (C) | null | 2016-08-21 | ABVD | null | null | CARBOPLATIN + ETOPOSIDE | 101212854 |
| 190007209 | 190006778 | 1.59 | 63.4 | Curative (C) | 2017-06-28 | 2017-09-21 | Capecitabine + Oxaliplatin 21day | 02 | N | CARBOPLATIN + ETOPOSIDE | 101138951 |
| 190007224 | 190006779 | 1.71 | 53.5 | Adjuvant (A) | null | 2019-06-26 | EW EuroEwing 2012 Arm B CE | null | null | CARBOPLATIN + ETOPOSIDE | 101541594 |
| 190007244 | 190006780 | null | 56 | Curative (C) | 2022-03-08 | 2022-03-29 | NIVOLUMAB | 02 | N | GEMCITABINE | 100052913 |
| 190007250 | 190006781 | 1.75 | 79.6 | Neo-adjuvant (N) | 2011-10-09 | 2022-05-01 | EW Rel rEECur Gemcitabine/Docetaxel | 02 | N | PACLITAXEL | 100855440 |
| 190007260 | 190006782 | null | 102.2 | null | 2020-03-01 | 2020-03-28 | CARBOPLATIN + PACLITAXEL | 02 | null | CARBOPLATIN + PACLITAXEL | 100943121 |
| 190007274 | 190006783 | 1.6 | 70.3 | Palliative (P) | 2017-12-27 | 2018-01-09 | Cisplatin | 2 | null | CISPLATIN | 101239029 |
| 190007279 | 190006784 | 0 | 23.3 | Curative (C) | 2020-07-10 | 2020-07-15 | EW Rel rEECur Topotecan/Cyclophosphamide | 02 | null | PACLITAXEL | 100632624 |
| 190007286 | 190006785 | 1.84 | 16.3 | Curative (C) | 2016-03-22 | 2016-07-29 | NB BEACON Temozolomide Irinotecan | 02 | N | TEMOZOLOMIDE | 100927376 |
| 190007302 | 190006786 | 0 | 38.9 | Palliative (P) | null | 2018-06-10 | OST Rel Ifosfamide Etoposide | 02 | N | PEMBROLIZUMAB | 100186441 |
| 190007307 | 190006787 | 1.84 | 62.2 | null | 2018-11-25 | 2018-12-20 | Ifosfamide | 01 | N | ABEMACICLIB + FULVESTRANT | 101234427 |
| 190007313 | 190006788 | 1.56 | 75 | Curative (C) | 2020-04-27 | 2020-05-12 | Cisplatin +Fluorouracil (3 wk) | N | Y | TRIAL UNSPECIFIED | 100439831 |
| 190007342 | 190006789 | 1.8 | 75 | null | 2018-10-24 | 2019-07-08 | EURAMOS TRIAL | N | Y | TRIAL UNSPECIFIED | 100474435 |
| 190007377 | 190006790 | 1.68 | 62 | Curative (C) | 2018-06-09 | 2018-06-19 | ECX | 02 | null | CAPECITABINE + OXALIPLATIN | 101502456 |
| 190007383 | 190006791 | 1.86 | 115.3 | null | 2018-01-22 | 2018-01-25 | NB HRNBL-1 Isotretinoin | 02 | N | GEMCITABINE + TREOSULFAN | 100059284 |
| 190007387 | 190006792 | 1.75 | 84.1 | Curative (C) | null | 2021-02-28 | null | 02 | N | CAPECITABINE | 100051375 |
| 190007402 | 190006793 | 1.74 | 47.2 | null | 2016-09-11 | 2016-09-11 | Trial Unspecified | 01 | N | FLUOROURACIL + IRINOTECAN | 100907940 |
| 190007411 | 190006794 | 1.78 | 90.8 | Neo-adjuvant (N) | null | 2021-04-08 | Cyclophosphamide + Topotecan | null | null | CAPECITABINE + OXALIPLATIN | 100663253 |
| 190007429 | 190006795 | 1.67 | 65.5 | null | null | 2016-12-08 | Docetaxel | null | null | CAPECITABINE + OXALIPLATIN | 101061738 |
| 190007433 | 190006796 | 1.71 | 66 | Neo-adjuvant (N) | 2022-05-14 | 2022-05-22 | Carboplatin AUC 6 - 10 | null | null | CARBOPLATIN | 100337818 |
| 190007440 | 190006797 | 1.6 | 95 | null | null | 2016-08-01 | PAM x 2 pre-surgery (cycles 1&2) | 02 | N | CISPLATIN + GEMCITABINE | 101535088 |
| 190007446 | 190006798 | 0 | 36 | Palliative (P) | 2019-09-07 | 2020-01-20 | EURO-EWING | 02 | N | CAPECITABINE + OXALIPLATIN | 101122694 |
| 190007452 | 190006799 | 1.7 | 58.3 | Neo-adjuvant (N) | null | 2014-12-10 | Cisplatin 7 day | 02 | null | CISPLATIN | 101061886 |
| 190007453 | 190006800 | 1.11 | 45 | Palliative (P) | 2016-08-07 | 2017-01-13 | Cisplatin 7 day | 2 | N | CISPLATIN | 100432894 |
| 190007472 | 190006801 | null | 83.999 | Curative (C) | 2018-11-02 | 2018-11-13 | EW EuroEwing 2012 Arm B VDC/IE | 02 | N | TEMOZOLOMIDE | 101086787 |
| 190007488 | 190006802 | 1.62 | 73.5 | Curative (C) | 2016-10-29 | 2016-11-10 | IPILIMUMAB + NIVOLUMAB | 02 | Y | EW EUROEWING 2012 ARM A VAI | 101416184 |
| 190007499 | 190006803 | 1.55 | 90.8 | null | 2018-06-23 | 2018-12-07 | Cisplatin + Radiotherapy | 01 | null | CISPLATIN | 101176230 |
| 190007503 | 190006804 | 1.63 | null | Curative (C) | null | 2019-04-19 | Capecitabine + Oxaliplatin 21day | 02 | N | BEVACIZUMAB | 101464057 |
| 190007521 | 190006805 | 0 | 28.6 | Curative (C) | 2021-06-06 | 2021-06-06 | CARBOPLATIN + ETOPOSIDE | 02 | null | CARBOPLATIN + ETOPOSIDE | 101655712 |
| 190007546 | 190006806 | 1.78 | 74.7 | Palliative (P) | 2019-04-14 | 2019-05-10 | Gemcitabine weekly | 01 | N | CARBOPLATIN + DOCETAXEL | 101183946 |
| 190007573 | 190006808 | 1.57 | 56.9 | null | null | 2018-07-28 | CARBOPLATIN + ETOPOSIDE | 02 | Y | DOXORUBICIN + METHOTREXATE | 100858964 |
| 190007589 | 190006809 | 1.61 | 21 | null | 2021-01-22 | 2021-01-26 | OST Euramos 1 Closed Trial - M | 02 | N | TRIAL UNSPECIFIED | 101819953 |
| 190007621 | 190006810 | 1.8 | 61.8 | Curative (C) | 2017-09-09 | 2017-09-23 | EW Rel rEECur Gemcitabine/Docetaxel + GCSF | 02 | null | CARBOPLATIN + GEMCITABINE | 100261518 |
| 190007623 | 190006811 | 1.62 | 91.6 | 03 | 2018-01-03 | 2018-06-03 | Cisplatin + Doxorubicin | 02 | N | CARBOPLATIN + GEMCITABINE | 100179928 |
| 190007634 | 190006812 | 1.62 | 18.9 | null | 2016-05-03 | 2016-05-03 | Capecitabine + Oxaliplatin 21day | null | N | CARBOPLATIN + FLUOROURACIL | 100639159 |
| 190007635 | 190006813 | 1.66 | 77.45 | null | null | 2016-05-19 | OST Euramos 1 Closed Trial - M | 02 | N | FLUOROURACIL + MITOMYCIN | 100693012 |
| 190007642 | 190006814 | 1.75 | 68.8 | Palliative (P) | 2018-12-23 | 2018-12-23 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | CISPLATIN | 100590887 |
| 190007645 | 190006815 | 1.49 | 49.1 | Adjuvant (A) | null | 2016-09-25 | CISPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + ETOPOSIDE | 100261474 |
| 190007649 | 190006816 | 1.84 | 94.7 | Palliative (P) | null | 2017-06-02 | Capecitabine + Oxaliplatin 21day | N | null | CARBOPLATIN + GEMCITABINE | 100001004 |
| 190007654 | 190006817 | 1.82 | 101 | Palliative (P) | 2017-07-14 | 2017-08-12 | CARBOPLATIN | 02 | Y | CARBOPLATIN | 100572959 |
| 190007678 | 190006818 | 1.68 | 76.9 | Adjuvant (A) | 2016-08-26 | 2016-08-26 | EW EuroEwing 2012 Arm A VAC | null | null | PEMBROLIZUMAB | 101435177 |
| 190007680 | 190006819 | 1.6 | 84 | Curative (C) | null | 2016-10-18 | CAPECITABINE + IRINOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 100528330 |
| 190007686 | 190006820 | 1.58 | 78.6 | null | 2022-01-25 | 2022-01-28 | Cisplatin + Doxorubicin | 01 | null | CAPECITABINE + OXALIPLATIN | 101026186 |
| 190007701 | 190006821 | 1.3 | 22.5 | Adjuvant (A) | 2020-04-28 | 2020-04-28 | DHAP | 02 | N | FLUOROURACIL + IRINOTECAN | 100415934 |
| 190007716 | 190006822 | 1.74 | 66.8 | Palliative (P) | 2020-02-16 | 2020-03-16 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101506535 |
| 190007727 | 190006823 | 1.63 | 88.8 | Adjuvant (A) | 2019-01-01 | 2019-01-08 | Rituximab | 02 | N | TOPOTECAN | 101212824 |
| 190007749 | 190006824 | 1.73 | 12.6 | Curative (C) | 2021-01-27 | 2021-02-11 | BEAM | 01 | N | CAPECITABINE + CARBOPLATIN | 100048445 |
| 190007755 | 190006825 | 1.7 | 66.3 | null | null | 2020-05-11 | Cisplatin + Radiotherapy | 02 | N | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 101408885 |
| 190007780 | 190006826 | null | 55.3 | null | 2018-05-17 | 2018-05-19 | Tivozanib | 02 | null | CISPLATIN + RT | 101755639 |
| 190007791 | 190006827 | 1.77 | 67.8 | null | null | 2019-05-19 | EURAMOS TRIAL | 02 | null | CARBOPLATIN + DOCETAXEL | 101649063 |